Microbiology

  1. Susceptibility of tree shrew to SARS-CoV-2 infection

    1. Yuan Zhao
    2. Junbin Wang
    3. Dexuan Kuang
    4. Jingwen Xu
    5. Mengli Yang
    6. Chunxia Ma
    7. Siwen Zhao
    8. Jingmei Li
    9. Haiting Long
    10. Kaiyun Ding
    11. Jiahong Gao
    12. Jiansheng Liu
    13. Haixuan Wang
    14. Haiyan Li
    15. Yun Yang
    16. Wenhai Yu
    17. Jing Yang
    18. Yinqiu Zheng
    19. Daoju Wu
    20. Shuaiyao Lu
    21. Hongqi Liu
    22. Xiaozhong Peng

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Evaluation of 19 antiviral drugs against SARS-CoV-2 Infection

    1. Shufeng Liu
    2. Christopher Z. Lien
    3. Prabhuanand Selvaraj
    4. Tony T. Wang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Pervasive generation of non-canonical subgenomic RNAs by SARS-CoV-2

    1. Jason Nomburg
    2. Matthew Meyerson
    3. James A. DeCaprio

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Coronavirus, as a source of pandemic pathogens

    1. T. Konishi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. The coronavirus proofreading exoribonuclease mediates extensive viral recombination

    1. Jennifer Gribble
    2. Andrea J. Pruijssers
    3. Maria L. Agostini
    4. Jordan Anderson-Daniels
    5. James D. Chappell
    6. Xiaotao Lu
    7. Laura J. Stevens
    8. Andrew L. Routh
    9. Mark R. Denison

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Insight towards the effect of the multibasic cleavage site of SARS-CoV-2 spike protein on cellular proteases

    1. Kamal Shokeen
    2. Shambhavi Pandey
    3. Manisha Shah
    4. Sachin Kumar

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Comparison of commercial RT-PCR diagnostic kits for COVID-19

    1. Puck B. van Kasteren
    2. Bas van der Veer
    3. Sharon van den Brink
    4. Lisa Wijsman
    5. Jørgen de Jonge
    6. Annemarie van den Brandt
    7. Richard Molenkamp
    8. Chantal B.E.M. Reusken
    9. Adam Meijer

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. The anti-HIV Drug Nelfinavir Mesylate (Viracept) is a Potent Inhibitor of Cell Fusion Caused by the SARS-CoV-2 Spike (S) Glycoprotein Warranting further Evaluation as an Antiviral against COVID-19 infections

    1. Farhana Musarrat
    2. Vladimir Chouljenko
    3. Rafiq Nabi
    4. Achyut Dahal
    5. Seetharama D. Jois
    6. Konstantin G. Kousoulas

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. SARS-CoV-2 Isolation and Propagation from Turkish COVID-19 patients

    1. Cihan Tastan
    2. Bulut Yurtsever
    3. Gozde Sir
    4. Derya Dilek Kancagi
    5. Sevda Demir
    6. Selen Abanuz
    7. Utku Seyis
    8. Mulazim Yildirim
    9. Recai Kuzay
    10. Omer Elibol
    11. Serap Arbak
    12. Merve Acikel Elmas
    13. Selcuk Birdogan
    14. Eray Sahin
    15. Orhan Ozcan
    16. Ugur Sezerman
    17. Ercument Ovali

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Mapping the Immunodominance Landscape of SARS-CoV-2 Spike Protein for the Design of Vaccines against COVID-19

    1. Bao-zhong Zhang
    2. Ye-fan Hu
    3. Lin-lei Chen
    4. Yi-gang Tong
    5. Jing-chu Hu
    6. Jian-piao Cai
    7. Kwok-Hung Chan
    8. Ying Dou
    9. Jian Deng
    10. Hua-rui Gong
    11. Chaiyaporn Kuwentrai
    12. Wenjun Li
    13. Xiao-lei Wang
    14. Hin Chu
    15. Cai-hui Su
    16. Ivan Fan-Ngai Hung
    17. Thomas Chung Cheung Yau
    18. Kelvin Kai-Wang To
    19. Kwok Yung Yuen
    20. Jian-Dong Huang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 68 of 251 Next